Cargando…
Real-world effectiveness and safety of ustekinumab induction therapy for Korean patients with Crohn’s disease: a KASID prospective multicenter study
BACKGROUND/AIMS: We investigated the real-world effectiveness and safety of ustekinumab (UST) as induction treatment for Koreans with Crohn’s disease (CD). METHODS: CD patients who started UST were prospectively enrolled from 4 hospitals in Korea. All enrolled patients received intravenous UST infus...
Autores principales: | Oh, Kyunghwan, Hong, Hee Seung, Ham, Nam Seok, Lee, Jungbok, Park, Sang Hyoung, Yang, Suk-Kyun, Yoon, Hyuk, Kim, You Sun, Choi, Chang Hwan, Ye, Byong Duk |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Korean Association for the Study of Intestinal Diseases
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9911275/ https://www.ncbi.nlm.nih.gov/pubmed/36751044 http://dx.doi.org/10.5217/ir.2021.00173 |
Ejemplares similares
-
Corrigendum: Real-world effectiveness and safety of ustekinumab induction therapy for Korean patients with Crohn’s disease: a KASID prospective multicenter study
por: Oh, Kyunghwan, et al.
Publicado: (2023) -
Real-life effectiveness and safety of tofacitinib treatment in
patients with ulcerative colitis: a KASID multicenter cohort
study
por: Shin, Seung Hwan, et al.
Publicado: (2023) -
Real-world effectiveness and safety of adalimumab in Korean patients with intestinal Behcet’s disease: a Korean Association for the Study of Intestinal Diseases (KASID) multicenter study
por: Lee, Seung Bum, et al.
Publicado: (2023) -
Balloon-Assisted Enteroscopy for Retrieval of Small Intestinal Foreign Bodies: A KASID Multicenter Study
por: Kim, Jeongseok, et al.
Publicado: (2020) -
Clinical and Genetic Characteristics of Korean Patients Diagnosed with Chronic Enteropathy Associated with SLCO2A1 Gene: A KASID Multicenter Study
por: Hong, Hee Seung, et al.
Publicado: (2022)